NM_138413.4:c.212-21A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138413.4(HOGA1):​c.212-21A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.195 in 1,613,546 control chromosomes in the GnomAD database, including 31,362 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.20 ( 3050 hom., cov: 32)
Exomes 𝑓: 0.19 ( 28312 hom. )

Consequence

HOGA1
NM_138413.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:3

Conservation

PhyloP100: -1.86

Publications

18 publications found
Variant links:
Genes affected
HOGA1 (HGNC:25155): (4-hydroxy-2-oxoglutarate aldolase 1) The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]
HOGA1 Gene-Disease associations (from GenCC):
  • primary hyperoxaluria type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 10-97598754-A-G is Benign according to our data. Variant chr10-97598754-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 204254.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138413.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HOGA1
NM_138413.4
MANE Select
c.212-21A>G
intron
N/ANP_612422.2
HOGA1
NM_001134670.2
c.212-3103A>G
intron
N/ANP_001128142.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HOGA1
ENST00000370646.9
TSL:1 MANE Select
c.212-21A>G
intron
N/AENSP00000359680.4
ENSG00000249967
ENST00000370649.3
TSL:2
c.212-3103A>G
intron
N/AENSP00000359683.3
HOGA1
ENST00000370647.8
TSL:1
c.212-3103A>G
intron
N/AENSP00000359681.4

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29882
AN:
152074
Hom.:
3045
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.202
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.183
Gnomad ASJ
AF:
0.171
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.180
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.204
Gnomad OTH
AF:
0.183
GnomAD2 exomes
AF:
0.185
AC:
46483
AN:
251460
AF XY:
0.184
show subpopulations
Gnomad AFR exome
AF:
0.208
Gnomad AMR exome
AF:
0.154
Gnomad ASJ exome
AF:
0.162
Gnomad EAS exome
AF:
0.140
Gnomad FIN exome
AF:
0.204
Gnomad NFE exome
AF:
0.197
Gnomad OTH exome
AF:
0.173
GnomAD4 exome
AF:
0.195
AC:
284464
AN:
1461354
Hom.:
28312
Cov.:
34
AF XY:
0.194
AC XY:
141039
AN XY:
726992
show subpopulations
African (AFR)
AF:
0.203
AC:
6809
AN:
33474
American (AMR)
AF:
0.159
AC:
7123
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.167
AC:
4376
AN:
26134
East Asian (EAS)
AF:
0.115
AC:
4583
AN:
39696
South Asian (SAS)
AF:
0.184
AC:
15850
AN:
86248
European-Finnish (FIN)
AF:
0.203
AC:
10833
AN:
53414
Middle Eastern (MID)
AF:
0.169
AC:
973
AN:
5764
European-Non Finnish (NFE)
AF:
0.200
AC:
222269
AN:
1111530
Other (OTH)
AF:
0.193
AC:
11648
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
12425
24849
37274
49698
62123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7694
15388
23082
30776
38470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.197
AC:
29917
AN:
152192
Hom.:
3050
Cov.:
32
AF XY:
0.195
AC XY:
14542
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.202
AC:
8372
AN:
41528
American (AMR)
AF:
0.184
AC:
2808
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
593
AN:
3466
East Asian (EAS)
AF:
0.140
AC:
725
AN:
5182
South Asian (SAS)
AF:
0.181
AC:
871
AN:
4818
European-Finnish (FIN)
AF:
0.199
AC:
2103
AN:
10588
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.204
AC:
13871
AN:
68000
Other (OTH)
AF:
0.182
AC:
384
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1262
2524
3787
5049
6311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.195
Hom.:
5787
Bravo
AF:
0.194
Asia WGS
AF:
0.162
AC:
560
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
1
1
Primary hyperoxaluria type 3 (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.20
DANN
Benign
0.20
PhyloP100
-1.9
La Branchor
0.76
BranchPoint Hunter
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11817730; hg19: chr10-99358511; COSMIC: COSV65706328; COSMIC: COSV65706328; API